For more than a century, Mendelian genetics has shaped how we think about inheritance: one gene, one trait. It is a model that still echoes through textbooks—and one that is increasingly reaching its ...
Some modern theories suggest reality may contain far more than a single version of each person. From quantum mechanics to multiverse models, scientists argue that every possible outcome could exist ...
New study into ‘heritability’ shows that 50% of the variation in human lifespan could be down to genetics Some people who live to a great age put it down to an evening tot of whisky, others to staying ...
El Monte-based technology company Fulgent Genetics Inc. agreed to acquire selected assets of Bako Diagnostics, a pathology laboratory based in Alpharetta, GA, and to acquire StrataDx, a ...
Add Yahoo as a preferred source to see more of our stories on Google. Lily Phillips is back in the spotlight, and this time, the reaction is split right down the middle. Known for breaking a shocking ...
A massive global genetics study is reshaping how we understand mental illness—and why diagnoses so often pile up. By analyzing genetic data from more than six million people, researchers uncovered ...
Zydus Lifesciences Limited ( (IN:ZYDUSLIFE)) has issued an announcement. Zydus Lifesciences has signed an exclusive agreement with US-based Myriad Genetics to introduce a suite of advanced cancer-risk ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The developer behind ...
Drexel University has signed a landmark lease selecting Gattuso Development Partners’ and Vigilant Holdings’ best-in-class life science development, 3201 Cuthbert Street, as the future home for its ...
A surge of 147% in a single session is an unusual occurrence in biotech — and nearly unprecedented for a company that has spent years trading discreetly under the radar. However, that is precisely ...
It wasn't hard to be optimistic about the biotech's future, given its excellent news from the lab on Monday. Prognosticators fell over themselves publishing bullish new takes on the company the ...
Life sciences stocks are seeing a resurgence — and that's good news for Danaher . Connecting the dots to better times ahead for the struggling portfolio name, Jim Cramer thinks the industry turnaround ...